: J&J spinoff Kenvue files initial public offering


Kenvue Inc. KVUE, , the consumer products unit of Johnson & Johnson JNJ, +1.09%, late Wednesday filed its initial public offering as part of a previously disclosed spinoff plan for the business. Kenvue plans to trade on the New York Stock Exchange under the symbol KVUE with lead underwriters Goldman Sachs Group Inc. and JPMorgan Chase & Co. For the fiscal year ended Jan. 2, Kenvue reported $15.05 billion in net sales, and $2.03 billion in net income. With products such as Listerine mouth wash and Johnson’s Baby Shampoo, Kenuve summed up its business under the slogan, “Realize the extraordinary power of everyday care,” in its IPO prospectus. Shares of Johnson & Johnson traded flat in premarket trades.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Wall Street Journal: Silvergate lost more than $700 million selling assets to cover withdrawals during crypto selloff
Next articleSilvergate shares slide as crypto-focused bank says $8.1 billion withdrawn


Please enter your comment!
Please enter your name here